Clinical Cancer Research, Vol 3, Issue 11 2017-2024, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism

KR Brader, JK Wolf, MC Hung, D Yu, MA Crispens, KL van Golen and JE Price
Departments of Cell Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

The introduction of adenovirus 5 E1A into the SKOV3ip1 ovarian cancer cell line was shown previously to suppress HER2/neu expression and reduce the malignant potential of these cells (Yu et al., Cancer Res., 53: 891-898, 1993). In this report, we show that reduction of p185 in cells stably expressing E1A protein was coincident with increased sensitivity to cytotoxic agents. The LD50 of cisplatin was reduced 6-fold, and the LD50 of paclitaxel and doxorubicin was reduced 10-fold in E1A-expressing cells compared with control cells. The growth of SKOV3ip1 and control cells was unchanged in the presence of 150 ng/ml of tumor necrosis factor-alpha, whereas the growth of E1A-expressing cells was reduced by 30 to 40%. When we used a physiologically obtainable concentration of paclitaxel (0.5 microM), DNA laddering consistent with apoptotic cell death was seen after a 24-h exposure in the E1A-expressing cells, whereas laddering and DNA fragmentation were only detected in DNA from control cells after longer exposure (48 h) at a 20-fold higher concentration of paclitaxel. The SKOV3ip1 cells do not express p53 protein; hence, the induction of apoptosis by paclitaxel is through a p53-independent pathway. Despite their diverse mechanisms of action, the cytotoxic effects of cisplatin, doxorubicin, paclitaxel, and tumor necrosis factor-alpha were enhanced by the expression of E1A proteins in the SKOV3ip1 ovarian cancer cells. This suggests that these agents share a common final pathway of cell killing, which may represent a potential therapeutic target in resistant ovarian cancers.

This article has been cited by other articles:

				C.-C. Wen, S.-A. Cheng, S.-P. Hsuen, Y.-L. Huang, Z.-K. Kuo, H.-F. Lee, C.-H. Kuo, J.-L. Du, and W.-B. Wang SV40 T/t-Common Polypeptide Specifically Induces Apoptosis in Human Cancer Cells that Overexpress HER2/neu Cancer Res., June 1, 2006; 66(11): 5847 - 5857. [Abstract] [Full Text] [PDF]

				S. Madhusudan, A. Tamir, N. Bates, E. Flanagan, M. E. Gore, D. P. J. Barton, P. Harper, M. Seckl, H. Thomas, N. R. Lemoine, et al. A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/neu Oncogene Clin. Cancer Res., May 1, 2004; 10(9): 2986 - 2996. [Abstract] [Full Text] [PDF]

				A. Cuconati, C. Mukherjee, D. Perez, and E. White DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells Genes & Dev., December 1, 2003; 17(23): 2922 - 2932. [Abstract] [Full Text] [PDF]

				Y. Liao and M.-C. Hung Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis Mol. Cell. Biol., October 1, 2003; 23(19): 6836 - 6848. [Abstract] [Full Text] [PDF]

				J. L. Cook, T. A. Miura, D. N. Ikle, A. M. Lewis Jr., and J. M. Routes E1A Oncogene-induced Sensitization of Human Tumor Cells to Innate Immune Defenses and Chemotherapy-induced Apoptosis in Vitro and in Vivo Cancer Res., June 15, 2003; 63(12): 3435 - 3443. [Abstract] [Full Text] [PDF]

				Y. Yang, C. McKerlie, S. H. Borenstein, Z. Lu, M. Schito, J. W. Chamberlain, and M. Buchwald Transgenic Expression in Mouse Lung Reveals Distinct Biological Roles for the Adenovirus Type 5 E1A 243- and 289-Amino-Acid Proteins J. Virol., July 29, 2002; 76(17): 8910 - 8919. [Abstract] [Full Text] [PDF]

				J. L. Cook, T. A. Walker, G. S. Worthen, and J. R. Radke Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha PNAS, July 23, 2002; 99(15): 9966 - 9971. [Abstract] [Full Text] [PDF]

				W. C. Russell Update on adenovirus and its vectors J. Gen. Virol., November 1, 2000; 81(11): 2573 - 2604. [Full Text]

				F. Meric, Y. Liao, W.-P. Lee, R. E. Pollock, and M.-C. Hung Adenovirus 5 Early Region 1A Does Not Induce Expression of the Ewing Sarcoma Fusion Product EWS-FLI1 in Breast and Ovarian Cancer Cell Lines Clin. Cancer Res., October 1, 2000; 6(10): 3832 - 3836. [Abstract] [Full Text]

				T. Stiewe, K. Parssanedjad, H. Esche, B. Opalka, and B. M. Pützer E1A Overcomes the Apoptosis Block in BCR-ABL+ Leukemia Cells and Renders Cells Susceptible to Induction of Apoptosis by Chemotherapeutic Agents Cancer Res., July 1, 2000; 60(14): 3957 - 3964. [Abstract] [Full Text]

				N. T. Ueno, C. Bartholomeusz, J. L. Herrmann, Z. Estrov, R. Shao, M. Andreeff, J. Price, R. W. Paul, P. Anklesaria, D. Yu, et al. E1A-mediated Paclitaxel Sensitization in HER-2/neu-overexpressing Ovarian Cancer SKOV3.ip1 through Apoptosis Involving the Caspase-3 Pathway Clin. Cancer Res., January 1, 2000; 6(1): 250 - 259. [Abstract] [Full Text]

				N. Sang, A. Severino, P. Russo, A. Baldi, A. Giordano, A. M. Mileo, M. G. Paggi, and A. De Luca RACK1 Interacts with E1A and Rescues E1A-induced Yeast Growth Inhibition and Mammalian Cell Apoptosis J. Biol. Chem., July 13, 2001; 276(29): 27026 - 27033. [Abstract] [Full Text] [PDF]